Sponsor Pipeline

Xinqiao Hospital of Chongqing Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
20
Active Trials
12
Recruiting
3
Phase 3
4
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-13 NCT07763405 Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Phase 4 Not Yet Recruiting
2026-08-12 NCT07760922 Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Phase 4 Not Yet Recruiting
Active Trials by Phase
Phase 4
3
Phase 3
2
Phase 2/3
1
Phase 2
4
Phase 1/2
1
Early Phase 1
3
Not specified
6
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07682922 Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke… Acute Ischemic Stroke Not Yet Recruiting
NCT07760922 Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Ischemic Stroke, Acute Not Yet Recruiting
NCT07763405 Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Ischemic Stroke, Acute Not Yet Recruiting
Phase 3
NCT06987305 Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window Stroke, Acute Ischemic Recruiting
NCT07347626 Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis Acute Ischemic Stroke Not Yet Recruiting
Phase 2/3
NCT05728333 Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke Stroke, Acute Ischemic Recruiting
Phase 2
NCT05147844 Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal… Nasopharyngeal Carcinoma Recruiting
NCT06279351 Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy… Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer Recruiting
NCT06953843 Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and… NSCLC Stage IV Without EGFR/ALK Mutation Recruiting
NCT06947694 A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy… NSCLC Stage IV Without EGFR/ALK Mutation Recruiting
Phase 1/2
NCT05455034 Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune… Pneumonitis Recruiting
Early Phase 1
NCT07349849 Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of… B-cell Malignancies Recruiting
NCT07349836 Application of mRNA Immunotherapy Technology in EB Virus Related Diseases EBV-associated Tumors Not Yet Recruiting
NCT07362758 Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory… Autoimmune Diseases Not Yet Recruiting
Not specified
NCT05486650 An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell… Non Small Cell Lung Cancer Recruiting
NCT05754203 Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for… Lung Cancer Recruiting
NCT05862259 A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced… Malignant Tumor Recruiting
NCT05230914 A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT) Stroke, Ischemic Recruiting
NCT06109376 Role of Hypothermia in Endovascular Stroke Thrombectomy Stroke, Acute Ischemic Not Yet Recruiting
NCT05909137 Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small… Immunotherapy Not Yet Recruiting
Disease Areas
Get alerts when Xinqiao Hospital of Chongqing's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free